ResearcherUniversity of Southern CaliforniaActive in the last 2 years

Jonathan Barajas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6759-6834; OpenAlex author ID A5112915847. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2025: 2 papers

Papers 2

Matrix stiffness influences drug resistance to gemcitabine analog and AZD 1775 combination in PDAC organoids. Co-author DOI 10.1371/journal.pone.0326550 ↗
ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Co-author DOI 10.3390/cancers17050870 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Edward Agyare · 2 shared papers, 2025 · strength 0.54
- Paper Matrix stiffness influences drug resistance to gemcitabine analog and AZD 1775 combination in PDAC organoids. DOI 10.1371/journal.pone.0326550 ↗
- Paper ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. DOI 10.3390/cancers17050870 ↗
Bo Han · 2 shared papers, 2025 · strength 0.54
- Paper Matrix stiffness influences drug resistance to gemcitabine analog and AZD 1775 combination in PDAC organoids. DOI 10.1371/journal.pone.0326550 ↗
- Paper ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. DOI 10.3390/cancers17050870 ↗
Saunjoo L. Yoon · 1 shared paper, 2025 · strength 0.30
- Paper Matrix stiffness influences drug resistance to gemcitabine analog and AZD 1775 combination in PDAC organoids. DOI 10.1371/journal.pone.0326550 ↗
Sherise Chantell Rogers · 1 shared paper, 2025 · strength 0.24
- Paper ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. DOI 10.3390/cancers17050870 ↗
Shuqing Zhao · 1 shared paper, 2025 · strength 0.24
- Paper ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. DOI 10.3390/cancers17050870 ↗
Ba X. Hoang · 1 shared paper, 2025 · strength 0.24
- Paper ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. DOI 10.3390/cancers17050870 ↗
Enrique I. Velazquez-Villarreal · 1 shared paper, 2025 · strength 0.24
- Paper ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. DOI 10.3390/cancers17050870 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.